Literature DB >> 10571071

Folding and self-assembly do not prevent ER retention and proteasomal degradation of asialoglycoprotein receptor H2a.

M Ayalon-Soffer1, S Kamhi-Nesher, G Z Lederkremer.   

Abstract

The human asialoglycoprotein receptor H2a precursor, a type II membrane protein, is cleaved to a soluble form that is secreted. Uncleaved precursor molecules are completely retained in the endoplasmic reticulum (ER) and degraded by the proteasome. To find out the causes of its fate we studied folding of H2a precursor, which was very similar to that of its alternatively spliced variant H2b which can exit to the Golgi. Proteasomal inhibition led to accumulation of folded rather than unfolded molecules. Accumulation of ER-retained H2a did not cause an unfolded protein response. Although the receptor is a heterooligomer of the H1 and H2 subunits, single expression led to some self-assembly. Whereas these homooligomers accumulated for H2b they were degraded for H2a. Translocation of H2a into the ER occurred efficiently. Therefore, the retention and proteasomal degradation of uncleaved membrane-bound H2a precursor from the ER do not involve aberrant translocation or misfolding and are not prevented by self-assembly.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10571071     DOI: 10.1016/s0014-5793(99)01321-6

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  2 in total

1.  A novel quality control compartment derived from the endoplasmic reticulum.

Authors:  S Kamhi-Nesher; M Shenkman; S Tolchinsky; S V Fromm; R Ehrlich; G Z Lederkremer
Journal:  Mol Biol Cell       Date:  2001-06       Impact factor: 4.138

2.  Separate roles and different routing of calnexin and ERp57 in endoplasmic reticulum quality control revealed by interactions with asialoglycoprotein receptor chains.

Authors:  Zehavit Frenkel; Marina Shenkman; Maria Kondratyev; Gerardo Z Lederkremer
Journal:  Mol Biol Cell       Date:  2004-02-20       Impact factor: 4.138

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.